UCIrvineCath Lab Essentials Program - 2015
Presented by
University of California, Irvine
School of Medicine
Division of Cardiology
January 24,2015
UCIrvineCath Lab Essentials Program - 2015
Doubletree Hotel Anaheim/OrangeCounty
100 The City Drive, Orange, CA
______
Course Description
The UCI Cath Lab Essentials Program is designed to expand upon and fill knowledge gaps brought to the attention of the cath lab faculty by the nurses and staff working in the cath lab. Cath lab nurses/staff require periodic updates on procedure techniques, basic hemodynamics, cardiovascular pathophysiology, angiography, and novel interventional procedures in this dynamic and changing field. The Society of Invasive Cardiac Professionals recommends periodic updates on current and new cath lab techniques and equipment.
Learning Objectives:
At the conclusion of this activity the participant should be able to:
- Obtain a basic understanding of hemodynamics in the cardiac Cath Lab, identify pressure measurement, artifacts and the application of pressure waveforms to the diagnosis of valvular abnormalities.
- Review the indications and contraindications for cardiac catheterization, identify complications and their management and understand the use of transfemoral and transradial catheterization techniques.
- Identify new methods for interventional cardiology procedures, the use of hemodynamic support devices, coronary stents, fractional flow reserve (FFR), intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
Target Audience: Catheterization lab nurses and technicians, cardiovascular nurses, and students and fellows-in-training and local community hospital physicians.
Accreditation Statement: The University of California, Irvine School of Medicine, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: The University of California, Irvine School of Medicine designates this live activity for a maximum of6AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. ASRT Designation: The American Society of Radiologic Technologists (ASRT) has approved this live activity for a maximum of 7 Category A Credits. Participants must complete the entire activity as designed and approvd to earn the credit. Disclosure Statement:It is the policy of the University of California, Irvine School of Medicine and the University of California CME Consortium to ensure balance, independence, objectivity and scientific rigor in all CME activities. Full disclosure of conflict resolution will be made in writing via handout materials or syllabus.
California Assembly Bill 1195
This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit the CME website at .
SYLLABUS DISCLOSURE
UCIRVINECATH LAB ESEENTIALS PROGRAM- 2015
All faculty presenting at activities certified for CME must complete the Faculty Disclosure form regardless of whether or not the activity is receiving commercial support. Documentation of disclosures to participants is required in this format.
UCI OCME requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity, and promote improvements or quality in healthcare. It is the policy of the UCI Office of Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in UCI OCME sponsored CME programs are expected to disclose to the activity participants any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the course content. The intent of this policy is identifying potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. It remains for the participants to determine whether the speaker’s outside interests reflect a possible bias in either the exposition or the conclusions presented.
Speaker Name / Name of Commercial Interest / Nature of Relevant Relationship / Conflict ResolutionMorton J. Kern, MD / ACIST Medical Systems
OPSENS
VolcanoTherapeutics
St. Jude Medical / Consultant
Consultant
Speaker
Speaker / As course director, I will to the best of my ability ensure that content is independent of com-mercial bias. Presentation has been peer reviewed for evidence base and fair balance. Will not discuss the use of any unlabelled/unapproved drugs or devices.
Pranav Patel, MD / N/A / N/A
Rajesh Banker, MD / N/A / N/A
Teferi Mitiku, MD / N/A / N/A
Alice Perlowski, MD / N/A / N/A
Arnold Seto, MD / N/A / N/A
This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.
Speaker Name / Product / Product UseMorton J. Kern, MD / None
Pranav Patel, MD / None
Rajesh Banker, MD / None
Teferi Mitiku, MD / None
Alice Perlowski, MD / None
Arnold Seto, MD / None
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine.
Program Faculty
______
COURSE CHAIRS
Morton J. Kern, MD
Professor of Medicine
Chief, Department of Medicine, LBVA
Associate Chief, Division of Cardiology, UCI
Pranav M. Patel, MD
Associate Professor of Medicine
Chief, Division of Cardiology
Director, Cardiac Catheterization Laboratory
University of California, Irvine
UCI – SCHOOL OF MEDICINE FACULTY
Arnold Seto, MD, MPH
Assistant Professor of Medicine
Interim Chief, Cardiology, LBVA
Interventional Cardiologist, LBVA and UCI
Teferi Mitiku, MD
Assistant Professor of Medicine
Electrophysiologist
University of California, Irvine
Alice Perlowski, MD
Assistant Professor of Medicine
Interventional Cardiologist, LBVA and UCI
Rajesh Banker, MD
Assistant Professor of Medicine
Electrophysiologist
University of California, Irvine
UC Irvine Cath Lab Essential Program - 2015
January 24, 2015
DoubleTree Hotel
07:30-07:55Registration with Coffee and Danish
Meet and Greet Faculty
07:55-08:00Welcome RemarksKern
08:00-08:30Patient Preparation, Safety, and Post Procedure CareSeto
08:30-09:00Coronary Angiography: Coronary Anatomy, Kern
Anomalies and the Ventricular Angiograms
09:00-09:30ECG and Arrhythmia in STEMI:Mitiku
What You Should Know
09:30-10:00Essential Skills: Understanding Access and Perlowski
Approach to PAD
10:00-10:15Break
10:15-10:45IVUS, OCT and NIRS: Different Views ofPatel
Atherosclerosis
10:45-11:15Coronary Stenting: The Appropriate use of FFRKern
11:15-11:45Hemodynamics for the Cath Lab and ICUSeto
11:45-12:30Lunch
12:30-1:00Advanced Hemodynamics: Essentials for TAVR Perlowski
and Mitral Valve Disease
1:00-1:30Essentials for Pacemakers and ICDsBanker
1:30-2:00LV Assist Devices for Hemodynamic Support: Patel
IABP, Impella, Tandem Heart
2:00-3:00Case Review and Complications: Kern/Patel
Presentations from Cath Lab Staff and Physicians
3:00Adjourn